Doses of olanzapine, risperidone, and haloperidol in clinical practice: Results of a prospective pharmaco-epidemiological study (EFESO)

J A Sacristán; Juan Carlos Gómez; KJ Gregor; Ángel L. Montejo; Eduard Vieta

doi:10.1016/s0920-9964(00)90760-6

Related publications

Article1999

PCN2: DOSES OF OLANZPINE, RISPERIDONE, AND HALOPERIDOL IN CLINICAL PRACTICE: RESULTS OF A PROSPECTIVE PHARMACOEOPIDEMIOGICAL STUDY (EFESO)

J A Sacristán, J.C. Gómez, KJ Gregor, Ángel L. Montejo, Eduard Vieta

Article2000

Doses of olanzapine, risperidone, and haloperidol used in clinical practice: Results of a prospective pharmacoepidemiologic study

José Antonio Sacristán, Juan‐Carlos Gómez, Ángel L. Montejo, Eduard Vieta, Karl J. Gregor

Article2018

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos, Michèle Cavo, Sandra Lejniece, Meral Beksaç, Mohamed Amine Bekadja, Wojciech Legieć, Meletios A Dimopoulos, Svetlana Stankovic, María Soledad Durán, Valerio De Stefano, Alessandro Corso, Yulia Kochkareva, Edward Laane, Christian Berthou, Hans Salwender, Zvenyslava Masliak, Valdas Pečeliūnas, Wolfgang Willenbacher, João Pedro Silva, Vernon Louw, ,

Article2012

Long-term outcome after statin treatment in routine clinical practice: results from a prospective PCI cohort study

Jannet A. Eindhoven, Yoshinobu Onuma, Rohit M. Oemrawsingh, Joost Daemen, Josephine van Nierop, Peter de Jaegere, Eric Boersma, Patrick W. Serruys, Ron van Domburg

EuroIntervention

Article2003

A 12-Week, Double-blind Comparison of Olanzapine vs Haloperidol in the Treatment of Acute Mania

Mauricio Tohen, Joseph F. Goldberg, Ana González‐Pinto, J.-M. Azorin, Eduard Vieta, Marie-Christine Hardy-Bayle, William Lawson, Robin Emsley, Fan Zhang, Robert W. Baker, Richard C. Risser, M. Namjoshi, Angela R. Evans, Alan Breier